Drug intelligence / Profile preview

diphyllin

Development stage
Preclinical
Modality
Small Molecules
Administration
In Vitro (no Established Pharmaceutical Route)
01

Overview

Diphyllin is a natural arylnaphthalide lignan extracted from several tropical plants, notably Cleistanthus collinus and Justicia gendarussa, with a history of use in traditional Chinese medicine. It is a potent and selective inhibitor of vacuolar (H^+^) ATPase (V-ATPase), interfering with endosomal acidification essential for viral entry and replication. Diphyllin exhibits broad-spectrum antiviral activity against numerous enveloped RNA and DNA viruses, including tick-borne encephalitis virus, West Nile virus, Zika virus, Rift Valley fever virus, rabies virus, herpes simplex virus type 1, and has also been tested against Ebola virus and SARS-CoV-2. In oncology, diphyllin inhibits V-ATPase in cancer cell lines, impacting mTORC1/HIF-1α/VEGF signaling and suppressing proliferation, angiogenesis, and metastasis. Diphyllin generally shows low cytotoxicity in mammalian cells at effective concentrations.

Other names
9-(1,3-benzodioxol-5-yl)-4-hydroxy-6,7-dimethoxy-3H-benzo[f][2]benzofuran-1-oneUNII-W4PN5LDP26UNII-W-4PN5LDP26UNII-W 4PN5LDP26
02

Targets

V-ATPase (Vacuolar-type H+-ATPase)VEGFA (Vascular endothelial growth factor A)HIF1A (Hypoxia-inducible factor 1-alpha)Mechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on diphyllin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diphyllin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call